CRS-3123

DB12262InvestigationalSmall molecule

CRS3123 has been used in trials studying the treatment of Clostridial Infection and Clostridium Difficile Colitis.

Chemical structure of CRS-3123
Formula / weight
C19H19Br2N3O2S · 513.25 g/mol (avg)
Code names
CRS-3123 · REP-3123

Resolves to

Compound
UNII2P987FW4E8CAS1013915-71-3PubChem16744283
Structure
InChIKeyNNTYBKTXMKBRFA-CQSZACIVSA-NSMILESBrC1=CC2=C(OCC[C@H]2NCCCNC2=CC(=O)C3=C(N2)C=CS3)C(Br)=C1

What you can answer from here — as of April 23, 2025

4Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of CRS-3123, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In